Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_assertion type Assertion NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_head.
- NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_assertion description "[When the severity of gastric atrophy was classified into the following three groups: non-atrophy (NA) (atrophy score=0 and metaplasia score=0); severe atrophy (SA) (atrophy score?2 or metaplasia score?2) and mild atrophy (MA) (all others), both the GSTT1 and GSTM1 null genotypes held significantly higher risk for developing more severe gastric atrophy (GSTT1 null, SA vs. others: OR=1.95, 95% CI=1.07-3.52, p=0.028, GSTM1 null, NA vs. others: OR=2.57, 95% CI=1.16-5.67, p=0.019, SA vs. others: OR=1.90, 95% CI=1.06-3.42, p=0.032).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_provenance.
- NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_assertion evidence source_evidence_literature NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_provenance.
- NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_assertion SIO_000772 21508403 NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_provenance.
- NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_assertion wasDerivedFrom befree-20150227 NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_provenance.
- NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_assertion wasGeneratedBy ECO_0000203 NP437594.RALyWqYaoM-J_3yH1W71BMzd_ztLzbIYeS9BkJqBoTQpk130_provenance.